Nucana Stock Analysis

NCNA -  USA Stock  

USD 2.89  0.04  1.37%

The big decline in price over the last few months for Nucana Plc ADRmay encourage investors to take a closer look at the firm as it is trading at a share price of 2.89 on 143,106 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in May. However, diversifying your holdings with Nucana Plc or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.52. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Nucana Plc ADR partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

 
Refresh
The Nucana Plc stock analysis report makes it easy to digest most publicly released information about Nucana Plc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Nucana stock analysis module also helps to analyze the Nucana Plc price relationship with some important fundamental indicators such as market cap and management efficiency.

Nucana Stock Analysis Notes

About 50.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nucana Plc ADR recorded a loss per share of 1.21. The entity had not issued any dividends in recent years. NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom. Nucana Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. To find out more about Nucana Plc ADR contact Hugh Griffith at 44 13 1357 1111 or learn more at http://www.nucana.com.

Nucana Plc ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nucana Plc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nucana Plc ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nucana Plc ADR generates negative expected return over the last 90 days
Nucana Plc ADR has high historical volatility and very poor performance
Nucana Plc ADR has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (36.48 M).
Nucana Plc ADR currently holds about 78.62 M in cash with (23.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52.
Nucana Plc ADR has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: NuCana plc - ADR gains 0.3330 percent for June 14 - Equities.com

Nucana Plc ADR Upcoming and Recent Events

Earnings reports are used by Nucana Plc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nucana Plc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report18th of August 2021
Next Earnings Report18th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End3rd of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Nucana Largest EPS Surprises

Earnings surprises can significantly impact Nucana Plc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-08-19
2020-06-30-0.2236-0.2506-0.02712 
2021-05-19
2021-03-31-0.2288-0.269-0.040217 
2019-05-14
2019-03-31-0.2613-0.21950.041815 
View All Earnings Estimates

Nucana Plc SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Nucana Plc prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Nucana Plc investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Nucana Plc ADR specific information freely available to individual and institutional investors to make a timely investment decision.
24th of May 2021
Other Events
View
19th of May 2021
Other Events
View
19th of April 2021
Other Events
View
12th of April 2021
Other Events
View
8th of March 2021
Unclassified Corporate Event
View
4th of March 2021
Other Events
View
26th of February 2021
Unclassified Corporate Event
View
16th of February 2021
Unclassified Corporate Event
View

Nucana Plc Thematic Classifications

In addition to having Nucana Plc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters IdeaCancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

Nucana Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 152.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nucana Plc's market, we take the total number of its shares issued and multiply it by Nucana Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Nucana Profitablity

Nucana Plc's profitability indicators refer to fundamental financial ratios that showcase Nucana Plc's ability to generate income relative to its revenue or operating costs. If, let's say, Nucana Plc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Nucana Plc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Nucana Plc's profitability requires more research than a typical breakdown of Nucana Plc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.34) (0.37) 
Return on Average Equity(0.38) (0.40) 
Return on Invested Capital(4.81) (5.19) 

Management Efficiency

The entity has return on total asset (ROA) of (26.97) % which means that it has lost $26.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (48.03) %, meaning that it created substantial loss on money invested by shareholders. Nucana Plc management efficiency ratios could be used to measure how well nucana plc adr manages its routine affairs as well as how well it operates its assets and liabilities. As of June 17, 2021, Return on Average Assets is expected to decline to -0.37. In addition to that, Return on Average Equity is expected to decline to -0.4. As of June 17, 2021, Total Assets is expected to decline to about 97.3 M. In addition to that, Current Assets is expected to decline to about 92.3 M
Last ReportedProjected for 2021
Book Value per Share 2.83  2.77 
Enterprise Value over EBIT(1.00) (1.08) 
Enterprise Value over EBITDA(0.54) (0.58) 
Price to Book Value 1.16  1.72 
Tangible Assets Book Value per Share 2.94  2.87 
Enterprise Value26 M26.7 M
Tangible Asset Value103 M93.3 M

Technical Drivers

As of the 17th of June 2021, Nucana Plc secures the risk adjusted performance of (0.12), and Mean Deviation of 3.28. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nucana Plc ADR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Nucana Plc, which can be compared to its peers in the industry. Please verify Nucana Plc ADR coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Nucana Plc ADR is priced some-what accurately, providing market reflects its recent price of 2.89 per share. Please also check out Nucana Plc total risk alpha, which is currently at (1.36) to check the company can sustain itself at a future point.

Nucana Plc ADR Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Nucana Plc ADR more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Nucana Plc Predictive Daily Indicators

Nucana Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nucana Plc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nucana Plc Forecast Models

Nucana Plc time-series forecasting models is one of many Nucana Plc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nucana Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Nucana Plc Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nucana Plc stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nucana shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Nucana Plc. By using and applying Nucana Stock analysis, traders can create a robust methodology for identifying Nucana entry and exit points for their positions.
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors Phase Ib for patients with recurrent ovarian cancer Phase III clinical trials for the treatment of patients with biliary tract cancer Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

Current Nucana Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nucana analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nucana analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
18.0Strong Buy4Odds
Nucana Plc ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Nucana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nucana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nucana Plc ADR, talking to its executives and customers, or listening to Nucana conference calls.
Nucana Analyst Advice Details

Nucana Stock Analysis Indicators

Nucana Plc ADR stock analysis indicators help investors evaluate how Nucana Plc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nucana Plc shares will generate the highest return on investment. By understating and applying Nucana Plc stock analysis, traders can identify Nucana Plc position entry and exit signals to maximize returns.
Shares Percent Shares Out0.70%
Quick Ratio9.94
Fifty Two Week Low2.6400
Forward Price Earnings-0.03
Float Shares30.74M
Fifty Two Week High7.8300
Shares Short Prior Month236.33k
Average Daily Volume Last 10 Day1.89M
Average Daily Volume In Three Month483.79k
Enterprise Value To Ebitda-1.98
Fifty Day Average3.2771
Two Hundred Day Average4.6769
Additionally, see Stocks Correlation. Note that the Nucana Plc ADR information on this page should be used as a complementary analysis to other Nucana Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Nucana Plc Stock analysis

When running Nucana Plc ADR stock analysis, check to measure Nucana Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nucana Plc is operating at the current time. Most of Nucana Plc's stock examination focuses on studying past and present price action to predict the probability of Nucana Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nucana Plc's price. Additionally, you may evaluate how the addition of Nucana Plc to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
The market value of Nucana Plc ADR is measured differently than its book value, which is the value of Nucana that is recorded on the company's balance sheet. Investors also form their own opinion of Nucana Plc stock's value that differs from its market value or its book value, called intrinsic value, which is Nucana Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nucana Plc's market value can be influenced by many factors that don't directly affect Nucana Plc ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nucana Plc's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Nucana Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nucana Plc's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.